Market Tracker

02/17 5:16pm ET

Nymox Pharmaceutical Corp (NASDAQ:NYMX)

3.42
Delayed Data
As of Feb 17
 0.00 / 0.00%
Today’s Change
1.62
Today|||52-Week Range
5.79
+28.09%
Year-to-Date
No recent news for Nymox Pharmaceutical Corp.

Today’s Trading

Previous close3.42
Today’s open3.50
Day’s range3.36 - 3.50
Volume79,840
Average volume (3 months)253,013
Market cap$163.7M
Dividend yield--
Data as of 3:59pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)-269.23%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-6.38%
P/E ratioNM
Price/Sales44.43
Price/Book--

Competitors

 Today’s
change
Today’s
% change
STMLStemline Therapeutic...+0.40+6.25%
OPHTOphthotech Corp-0.14-3.02%
RDHLRedhill Biopharma Lt...+0.07+0.71%
DVAXDynavax Technologies...-0.08-1.84%
Data as of 3:59pm ET, 02/17/2017

Financials

Last reporting dateMarch 11, 2016
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$2.8M
Annual profit (last year)-$17.9M
Net profit margin-647.67%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Paul Averback
Chief Financial Officer
Erik Danielsen
Corporate headquarters
Saint-Laurent, Quă©bec

Forecasts